Canadian team treating brain diseases with therapeutic ultrasound guided by MRI

An application of MR-guided focused ultrasound (MRgFUS) is showing good promise for treating a number of brain diseases non-invasively and without harming healthy tissue surrounding the target.

The technique is being advanced by professors and clinicians at the University of Calgary.

The news office of U-Calgary’s Hotchkiss Brain Institute reports on the work by way of announcing an infusion of $3.2 million (Canadian) in research funding from the independent, not-for-profit Canada Foundation for Innovation.

Research team leader Bruce Pike, PhD, calls the budding technology “revolutionary,” underscoring that it enables precise neurosurgery to be performed without so much as breaking the patient’s skin.

“We are also exploring the technology’s ability to help deliver drugs directly to brain tumors and to precisely stimulate brain tissue on the millimeter scale,” Pike adds. “This remarkable technology offers a vast range of potential applications—from treating movement disorders to epilepsy to Alzheimer’s disease.”

In fact, that future has already begun to arrive: Researchers working on the project have so far completed several procedures.

Read the rest:

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer. 

Trimed Popup
Trimed Popup